News & Insights
Sort By
Insights 1 result
Insights
|November 9, 2017
The Most Important New Privacy Law in a Generation: The GDPR
If you have any questions regarding the matters covered in this client alert, you may contact the following GD attorneys:
Events 1 result
Events
|February 7, 2024
Webinar: “What’s Market” in University Licenses in the Life Science Industry
Gunderson Dettmer Strategic Transactions and Licensing partner Brendan McCarthy hosted the webinar “’What’s Market’ in University Licenses in the Life Sciences Industry” to discuss the key economic terms in university license agreements.
Client News 27 Results
Client News
|August 6, 2026
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals
Tarsus Pharmaceuticals announces its definitive agreement to acquire Alkeus Pharmaceuticals, a privately held retinal disease-focused biotechnology company developing gildeuretinol (ALK-001), an investigational once-daily oral therapy for Stargardt disease.
Client News
|December 4, 2025
Replicate Bioscience Announces Collaborative Agreement with Instituto Butantan
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology, announces a collaboration agreement with Instituto Butantan, a leading nonprofit producer of immunobiologic products in Brazil.
Client News
|May 27, 2025
Cambridge-based biopharmaceutical company pioneering RNAi-based medicine, City Therapeutics, announces its $ 1 billion strategic collaboration with Biogen Inc., a company focused on pioneering innovative science to deliver new medicines
Firm News 1 result
Firm News
|December 13, 2018
Gunderson Dettmer Announces New Partners
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP has announced the promotions of five associates to the partnership, effective January 1, 2019.